Cargando…

Comparison of in-hospital COVID-19 related outcomes between COVISHIELD and COVAXIN recipients

Detalles Bibliográficos
Autores principales:	Suri, Tejas M., Ghosh, Tamoghna, Arunachalam, M, Vadala, Rohit, Vig, Saurabh, Bhatnagar, Sushma, Mohan, Anant
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9200197/ https://www.ncbi.nlm.nih.gov/pubmed/35488692 http://dx.doi.org/10.4103/lungindia.lungindia_141_22

Ejemplares similares

COVID-19 vaccine uptake among patients undergoing treatment for lung cancer: A cross-sectional study in India
por: Suri, Tejas Menon, et al.
Publicado: (2023)

Clinical profile and in-hospital outcomes of COVID-19 among adolescents at a tertiary care hospital in India
por: Ghosh, Tamoghna, et al.
Publicado: (2022)

“Covishield and Covaxin” – India's contribution to global COVID-19 pandemic
por: Raina, Sunil Kumar, et al.
Publicado: (2021)

Immunogenic and reactogenic efficacy of Covaxin and Covishield: a comparative review
por: Das, Swarnali, et al.
Publicado: (2022)

Adverse effects after first and second dose of covishield and covaxin: A longitudinal study
por: Mittal, Amit, et al.
Publicado: (2022)

Impact of various hematological and biochemical parameters on mortality in coronavirus disease 2019 (COVID-19): A single-center study from North India
por: Ghosh, Tamoghna, et al.
Publicado: (2022)

2371. A study to describe the pattern of cutaneous adverse effects of COVID-19 vaccines (Covishield and Covaxin )
por: Mitra, Debdeep, et al.
Publicado: (2023)

Effectiveness of Covid-19 vaccines (Covishield(TM) and Covaxin (®)) in healthcare workers in Mumbai, India: A retrospective cohort analysis
por: Contractor, Aashish, et al.
Publicado: (2022)

Anti SARS-CoV 2 IgG antibody response in fully vaccinated Covishield (AZD1222) and Covaxin (BBV-152) recipients: a study done in southern part of West Bengal, India
por: Satpathi, Partha Sarathi, et al.
Publicado: (2022)

Estimation of SARS-CoV-2 IgG Antibodies in Healthcare Worker-Administered Covishield and Covaxin Vaccines at a Tertiary Care Hospital in Jharkhand, India
por: Singh, Bishnupati, et al.
Publicado: (2023)

Polyfunctional CD4 T-cells correlating with neutralising antibody is a hallmark of COVISHIELD(TM) and COVAXIN(®) induced immunity in COVID-19 exposed Indians
por: Rakshit, Srabanti, et al.
Publicado: (2023)

SARS-CoV-2 Delta and delta derivatives impact on neutralization of Covishield recipient sera
por: Sahay, Rima R., et al.
Publicado: (2022)

Prevalence, severity, and risk factor of breakthrough infection after vaccination with either the Covaxin or the Covishield among healthcare workers: A nationwide cross-sectional study
por: Krishna, Bhavya, et al.
Publicado: (2022)

WCN23-0557 Higher pro-inflammatory cytokines are associated with anti-SARS-CoV-2 spike protein-specific seroconversion after two doses of COVAXIN™, COVISHIELD™ vaccination in renal transplant recipients
por: Prasad, N., et al.
Publicado: (2023)

Scrambler therapy – A novel treatment approach for chronic postoperative pain
por: Kashyap, Komal, et al.
Publicado: (2020)

Covaxin: An overview of its immunogenicity and safety trials in India
por: Sharma, Rohit, et al.
Publicado: (2021)

Concerns and Coping Strategies of Persons Under Institutional Quarantine During SARS-CoV-2 Pandemic
por: Singh, Neha, et al.
Publicado: (2020)

Covaxin-Induced Lymphocytic Myocarditis
por: Mittal, Nitish, et al.
Publicado: (2022)

Clinical outcomes in individuals hospitalized with SARS-CoV-2 Delta variant (B.1.617.2) who had been vaccinated with Covishield (ChAdOx1) and Covaxin (BBV-152)
por: Munigela, Apoorva, et al.
Publicado: (2022)

Pityriasis Rosea Following Covaxin (BBV152) Vaccination for COVID-19
por: Singh, Bhabani S. T. P., et al.
Publicado: (2022)

Effectiveness of BBV152/Covaxin and AZD1222/Covishield vaccines against severe COVID-19 and B.1.617.2/Delta variant in India, 2021: a multi-centric hospital-based case-control study
por: Bhatnagar, Tarun, et al.
Publicado: (2022)

Herpes Zoster Following Covaxin Receipt
por: Muhie, Oumer Abdu, et al.
Publicado: (2021)

Impact of prior vaccination with Covishield(TM) and Covaxin® on mortality among symptomatic COVID-19 patients during the second wave of the pandemic in South India during April and May 2021: a cohort study
por: Abhilash, Kundavaram Paul Prabhakar, et al.
Publicado: (2022)

Seroconversion Rate After SARS-CoV-2 Infection and Two Doses of Either ChAdOx1-nCOV COVISHIELD™ or BBV-152 COVAXIN™ Vaccination in Renal Allograft Recipients: An Experience of Two Public and Private Tertiary Care Center
por: Prasad, Narayan, et al.
Publicado: (2022)

Immunogenicity and safety of homologous and heterologous booster vaccination of ChAdOx1 nCoV-19 (COVISHIELD™) and BBV152 (COVAXIN®): a non-inferiority phase 4, participant and observer-blinded, randomised study
por: Rose, Winsley, et al.
Publicado: (2023)

COVID-19 in Kidney Transplant Recipients Vaccinated With Oxford–AstraZeneca COVID-19 Vaccine (Covishield): A Single-center Experience From India
por: Meshram, Hari Shankar, et al.
Publicado: (2021)

Holistic approach to patient care in COVID-19: Need of an hour
por: Kumar, Rohit, et al.
Publicado: (2020)

Temporal evolution of diaphragm thickness and diaphragm excursion among subjects hospitalized with COVID-19: A prospective observational study
por: Hadda, Vijay, et al.
Publicado: (2023)

Humoral Immune Response to BBV152 (Covaxin) SARS-CoV-2 Vaccine in Patients on Hemodialysis
por: Vijayaraghavan, Radha, et al.
Publicado: (2023)

Comparison of Mc Grath-MAC and C-MAC video laryngoscopes for intubation in a COVID simulated mannequin by novice users wearing face protective gear: A randomized crossover trial
por: Vig, Saurabh, et al.
Publicado: (2021)

Protective efficacy of COVAXIN® against Delta and Omicron variants in hamster model
por: Yadav, Pragya D., et al.
Publicado: (2022)

Impact of Scrambler Therapy on Pain Management and Quality of Life in Cancer Patients: A Study of Twenty Cases
por: Kashyap, Komal, et al.
Publicado: (2017)

Falsified COVISHIELD products in India and Uganda
Publicado: (2021)

Covishield vaccination and pulmonary thromboembolism: A coincidence or a causal association?
por: Divas, Rijal, et al.
Publicado: (2023)

Reduced neutralizing antibody response in naïve Covishield vaccinees against Omicron emphasizes booster vaccination
por: Yadav, Pragya D., et al.
Publicado: (2022)

Evaluation of immunogenicity post two doses of inactivated SARS-CoV-2 vaccine, Covaxin after six months
por: Sahay, Rima R., et al.
Publicado: (2022)

Concerns of a Post-Chemotherapy/Radiotherapy Patient of Nasopharyngeal Carcinoma Presenting with Sustained COVID-19 Infection
por: Shweta,, et al.
Publicado: (2020)

COVID-19 Real-Time RT-PCR: Does Positivity on Follow-up RT-PCR Always Imply Infectivity?
por: Suri, Tejas, et al.
Publicado: (2020)

Elevated neutralization of Omicron with sera of COVID-19 recovered and breakthrough cases vaccinated with Covaxin than two dose naïve vaccinees
por: Yadav, Pragya D., et al.
Publicado: (2022)

A young immunocompetent female with anterior mediastinal mass
por: Iyer, Hariharan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rg0jmel38infur7jr3sc94si4j